Amryt Provides Update on Regulatory Review Process for Oleogel-S10

Amryt Provides Update on Regulatory Review Process for Oleogel-S10. FDA PDUFA goal date extended by three months to February 28, 2022. DUBLIN, Ireland, and Boston MA, November 23, 2021, Amryt, a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing and commercializing novel treatments for rare diseases, today announces that...